|
1
|
Blume C and Davies DE: In vitro and ex
vivo models of human asthma. Eur J Pharm Biopharm. 84:394–400.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kumar RK and Foster PS: Modeling allergic
asthma in mice: Pitfalls and opportunities. Am J Respir Cell Mol
Biol. 27:267–272. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saw S, Kale SL and Arora N: Serine
protease inhibitor attenuates ovalbumin induced inflammation in
mouse model of allergic airway disease. PLoS One. 7:e411072012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamid Q and Tulic M: Immunobiology of
asthma. Annu Rev Physiol. 71:489–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paul WE and Zhu J: How are T(H)2-type
immune responses initiated and amplified? Nat Rev Immunol.
10:225–235. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Busse WW and Lemanske RF Jr: Asthma. N
Engl J Med. 344:350–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holgate ST: Pathogenesis of asthma. Clin
Exp Allergy. 38:872–897. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Medoff BD, Thomas SY and Luster AD: T cell
trafficking in allergic asthma: The ins and outs. Annu Rev Immunol.
26:205–232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schuijs MJ, Willart MA, Hammad H and
Lambrecht BN: Cytokine targets in airway inflammation. Curr Opin
Pharmacol. 13:351–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koshy S, Huq R, Tanner MR, Atik MA, Porter
PC, Khan FS, Pennington MW, Hanania NA, Corry DB and Beeton C:
Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats
a rat model of asthma. J Biol Chem. 289:12623–12632. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Webb GJ, Hirschfield GM and Lane PJ: OX40,
OX40L and autoimmunity: A comprehensive review. Clin Rev Allergy
Immunol. 50:312–332. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang YH and Liu YJ: Thymic stromal
lymphopoietin, OX40-ligand, and interleukin-25 in allergic
responses. Clin Exp Allergy. 39:798–806. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu YJ: Thymic stromal lymphopoietin and
OX40 ligand pathway in the initiation of dendritic cell-mediated
allergic inflammation. J Allergy Clin Immunol. 120:238–244. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seshasayee D, Lee WP, Zhou M, Shu J, Suto
E, Zhang J, Diehl L, Austin CD, Meng YG, Tan M, et al: In vivo
blockade of OX40 ligand inhibits thymic stromal lymphopoietin
driven atopic inflammation. J Clin Invest. 117:3868–3878. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Croft M, So T, Duan W and Soroosh P: The
significance of OX40 and OX40L to T-cell biology and immune
disease. Immunol Rev. 229:173–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
National Research and Council (US), .
Committee for the update of the guide for the care and use of
laboratory animals: Guide for the care and use of laboratory
animals. 8th. Washington (DC): National Academies Press (US);
2011
|
|
17
|
Wu Q, Tang Y, Hu X, Wang Q, Lei W, Zhou L
and Huang J: Regulation of Th1/Th2 balance through OX40/OX40L
signalling by glycyrrhizic acid in a murine model of asthma.
Respirology. 21:102–111. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salek-Ardakani S, Song J, Halteman BS,
Jember AG, Akiba H, Yagita H and Croft M: OX40 (CD134) controls
memory T helper 2 cells that drive lung inflammation. J Exp Med.
198:315–324. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee MY, Lee JA, Seo CS, Ha H, Lee NH and
Shin HK: Protective effects of Mentha haplocalyx ethanol extract
(MH) in a mouse model of allergic asthma. Phytother Res.
25:863–869. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Malmström V, Shipton D, Singh B,
Al-Shamkhani A, Puklavec MJ, Barclay AN and Powrie F: CD134L
expression on dendritic cells in the mesenteric lymph nodes drives
colitis in T cell-restored SCID mice. J Immunol. 166:6972–6981.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Haley KJ, Ciota A, Contreras JP, Boothby
MR, Perkins DL and Finn PW: Alterations in lung collectins in an
adaptive allergic immune response. Am J Physiol Lung Cell Mol
Physiol. 282:L573–L584. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang M, Fei X, Zhang GQ, Zhang PY, Li F,
Bao WP, Zhang YY and Zhou X: Role of neutralizing anti-murine
interleukin-17A monoclonal antibody on chronic ozone-induced airway
inflammation in mice. Biomed Pharmacother. 83:247–256. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arestides RS, He H, Westlake RM, Chen AI,
Sharpe AH, Perkins DL and Finn PW: Costimulatory molecule OX40L is
critical for both Th1 and Th2 responses in allergic inflammation.
Eur J Immunol. 32:2874–2880. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li YY, Chang JW, Chou WC, Liaw CC, Wang
HM, Huang JS, Wang CH and Yeh KY: Zoledronic acid is unable to
induce apoptosis, but slows tumor growth and prolongs survival for
non-small-cell lung cancers. Lung Cancer. 59:180–191. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lucas CD, Dorward DA, Sharma S, Rennie J,
Felton JM, Alessandri AL, Duffin R, Schwarze J, Haslett C and Rossi
AG: Wogonin induces eosinophil apoptosis and attenuates allergic
airway inflammation. Am J Respir Crit Care Med. 191:626–636. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carrero R, Cerrada I, Lledó E, Dopazo J,
García-García F, Rubio MP, Trigueros C, Dorronsoro A, Ruiz-Sauri A,
Montero JA and Sepúlveda P: IL1β induces mesenchymal stem cells
migration and leucocyte chemotaxis through NF-κB. Stem Cell Rev.
8:905–916. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lei W, Zeng DX, Zhu CH, Liu GQ, Zhang XQ,
Wang CG, Wang Q and Huang JA: The upregulated expression of
OX40/OX40L and their promotion of T cells proliferation in the
murine model of asthma. J Thorac Dis. 6:979–987. 2014.PubMed/NCBI
|
|
28
|
Kow NY and Mak A: Costimulatory pathways:
Physiology and potential therapeutic manipulation in systemic lupus
erythematosus. Clin Dev Immunol. 2013:2459282013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gramaglia I, Weinberg AD, Lemon M and
Croft M: OX40 ligand: A potent costimulatory molecule for
sustaining primary CD4 T cell responses. J Immunol. 161:6510–6517.
1998.PubMed/NCBI
|
|
30
|
Takeda I, Ine S, Killeen N, Ndhlovu LC,
Murata K, Satomi S, Sugamura K and Ishii N: Distinct roles for the
OX40-OX40 ligand interaction in regulatory and nonregulatory T
cells. J Immunol. 172:3580–3589. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Valzasina B, Guiducci C, Dislich H,
Killeen N, Weinberg AD and Colombo MP: Triggering of OX40 (CD134)
on CD4(+)CD25+ T cells blocks their inhibitory activity: A novel
regulatory role for OX40 and its comparison with GITR. Blood.
105:2845–2851. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ekkens MJ, Liu Z, Liu Q, Whitmire J, Xiao
S, Foster A, Pesce J, VanNoy J, Sharpe AH, Urban JF and Gause WC:
The role of OX40 ligand interactions in the development of the Th2
response to the gastrointestinal nematode parasite Heligmosomoides
polygyrus. J Immunol. 170:384–393. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miura S, Ohtani K, Numata N, Niki M, Ohbo
K, Ina Y, Gojobori T, Tanaka Y, Tozawa H, Nakamura M, et al:
Molecular cloning and characterization of a novel glycoprotein,
gp34, that is specifically induced by the human T-cell leukemia
virus type I transactivator p40tax. Mol Cell Biol. 11:1313–1325.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baum PR, Gayle RB III, Ramsdell F,
Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Baker E,
Sutherland GR, Clifford KN, et al: Molecular characterization of
murine and human OX40/OX40 ligand systems: Identification of a
human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J.
13:3992–4001. 1994.PubMed/NCBI
|
|
35
|
Stüber E, Neurath M, Calderhead D, Fell HP
and Strober W: Cross-linking of OX40 ligand, a member of the
TNF/NGF cytokine family, induces proliferation and differentiation
in murine splenic B cells. Immunity. 2:507–521. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stüber E and Strober W: The T cell-B cell
interaction via OX40-OX40L is necessary for the T cell-dependent
humoral immune response. J Exp Med. 183:979–989. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ohshima Y, Tanaka Y, Tozawa H, Takahashi
Y, Maliszewski C and Delespesse G: Expression and function of OX40
ligand on human dendritic cells. J Immunol. 159:3838–3848.
1997.PubMed/NCBI
|
|
38
|
Brocker T, Gulbranson-Judge A, Flynn S,
Riedinger M, Raykundalia C and Lane P: CD4 T cell traffic control:
In vivo evidence that ligation of OX40 on CD4 T cells by
OX40-ligand expressed on dendritic cells leads to the accumulation
of CD4 T cells in B follicles. Eur J Immunol. 29:1610–1616. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Imura A, Hori T, Imada K, Ishikawa T,
Tanaka Y, Maeda M, Imamura S and Uchiyama T: The human OX40/gp34
system directly mediates adhesion of activated T cells to vascular
endothelial cells. J Exp Med. 183:2185–2195. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rogers PR, Song J, Gramaglia I, Killeen N
and Croft M: OX40 promotes Bcl-xL and Bcl-2 expression and is
essential for long-term survival of CD4 T cells. Immunity.
15:445–455. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kinnear G, Wood KJ, Marshall D and Jones
ND: Anti-OX40 prevents effector T-cell accumulation and CD8+ T-cell
mediated skin allograft rejection. Transplantation. 90:1265–1271.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Flynn S, Toellner KM, Raykundalia C,
Goodall M and Lane P: CD4 T cell cytokine differentiation: The B
cell activation molecule, OX40 ligand, instructs CD4 T cells to
express interleukin 4 and upregulates expression of the chemokine
receptor, Blr-1. J Exp Med. 188:297–304. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vu MD, Clarkson MR, Yagita H, Turka LA,
Sayegh MH and Li XC: Critical, but conditional, role of OX40 in
memory T cell-mediated rejection. J Immunol. 176:1394–1401. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Murata K, Nose M, Ndhlovu LC, Sato T,
Sugamura K and Ishii N: Constitutive OX40/OX40 ligand interaction
induces autoimmune-like diseases. J Immunol. 169:4628–4236. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ueno H and Blanco P: OX40/OX40L axis: Not
a friend in autoimmunity. Oncotarget. 6:21779–21780. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gough MJ and Weinberg AD: OX40 (CD134) and
OX40L. Adv Exp Med Biol. 647:94–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hori T: Roles of OX40 in the pathogenesis
and the control of diseases. Int J Hematol. 83:17–22. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Redmond WL and Weinberg AD: Targeting OX40
and OX40L for the treatment of autoimmunity and cancer. Crit Rev
Immunol. 27:415–436. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Park BS, Hong GU and Ro JY: Foxp3(+)-Treg
cells enhanced by repeated low-dose gamma-irradiation attenuate
ovalbumin-induced allergic asthma in mice. Radiat Res. 179:570–583.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Obermeier F, Schwarz H, Dunger N, Strauch
UG, Grunwald N, Schölmerich J and Falk W: OX40/OX40L interaction
induces the expression of CXCR5 and contributes to chronic colitis
induced by dextran sulfate sodium in mice. Eur J Immunol.
33:3265–3274. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kay AB: The role of T lymphocytes in
asthma. Chem Immunol Allergy. 91:59–75. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang T, Zhang X, Wang M, Zhang J, Huang F,
Cai J, Zhang Q, Mao F, Zhu W, Qian H and Xu W: Activation of
mesenchymal stem cells by macrophages prompts human gastric cancer
growth through NF-κB pathway. PLoS One. 9:e975692014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Song J, So T and Croft M: Activation of
NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion
and survival. J Immunol. 180:7240–7248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Burrows KE, Dumont C, Thompson CL, Catley
MC, Dixon KL and Marshall D: OX40 blockade inhibits house dust mite
driven allergic lung inflammation in mice and in vitro allergic
responses in humans. Eur J Immunol. 45:1116–1128. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Robinson DP, Hall OJ, Nilles TL, Bream JH
and Klein SL: 17β-estradiol protects females against influenza by
recruiting neutrophils and increasing virus-specific CD8 T cell
responses in the lungs. J Virol. 88:4711–4720. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jandl K, Stacher E, Bálint Z, Sturm EM,
Maric J, Peinhaupt M, Luschnig P, Aringer I, Fauland A, Konya V, et
al: Activated prostaglandin D2 receptors on macrophages enhance
neutrophil recruitment into the lung. J Allergy Clin Immunol.
137:833–843. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jeon J, Kim Y, Kim H, Kang JS and Lee WJ:
Anti-inflammatory effect of alloferon on ovalbumin-induced asthma.
Immune Netw. 15:304–312. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bouchard JC, Beal DR, Kim J, Vaickus LJ
and Remick DG: Chemokines mediate ethanol-induced exacerbations of
murine cockroach allergen asthma. Clin Exp Immunol. 172:203–216.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Farres MN, Sabry MK, Ahmed EE, Elkady HM
and Mohamed NA: OX40 ligand: A potential costimulatory molecule in
atopic asthma. J Asthma. 51:573–577. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kaur D and Brightling C: OX40/OX40 ligand
interactions in T-cell regulation and asthma. Chest. 141:494–499.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lei W, Zhu CH, Zeng da X, Wang Q, Zhang
XQ, Chen YB, Mu CY and Huang JA: SOX40L: An important inflammatory
mediator in adult bronchial asthma. Ann Acad Med Singapore.
41:200–204. 2012.PubMed/NCBI
|
